Figure 7.
Overall survival (OS) and progression‐free survival (PFS) of diffuse large B‐cell lymphoma (DLBCL) patients among the signal‐regulatory protein‐α (SIRPα) expression groups. A, OS of all patients. B, PFS of all patients. C, OS of activated B‐cell (ABC) subtype. D, PFS of ABC subtype. E, OS of germinal center B‐cell (GCB) subtype. F, PFS of GCB subtype. Significantly worse OS and PFS of SIRPαhigh were observed in ABC subtype (P = .04 and P = .02, respectively). There were no significant differences in OS or PFS according to SIRPα expression in all patients and in GCB subtype